HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea · Delayed Price · Currency is KRW 6,600.00
+430.00 (6.97%)
Jul 14, 2026, 3:30 PM KST
HLB Pharmaceutical Market Cap
HLB Pharmaceutical has a market cap or net worth of 92.68 billion as of July 14, 2026. Its market cap has decreased by -65.54% in one year.
Market Cap
92.68B
Enterprise Value
93.13B
Revenue
236.59B
Ranking
n/a
PE Ratio
58.32
Stock Price
6,600.00
Market Cap Chart
Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 92.68B, an increase of 9.97%. That is a compound annual growth rate of 0.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 92.68B | -58.85% |
| Dec 30, 2025 | 225.24B | -33.44% |
| Dec 30, 2024 | 338.42B | 58.45% |
| Dec 28, 2023 | 213.58B | 43.49% |
| Dec 29, 2022 | 148.85B | -21.48% |
| Dec 30, 2021 | 189.57B | -21.05% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jeil Pharmaceutical Co.,Ltd | 149.07B |
| Dongwha Pharm.Co.,Ltd | 143.02B |
| Ilsung Is | 140.77B |
| CMG Pharmaceutical | 135.53B |
| Hyundai Pharmaceutical | 135.21B |
| Samil Pharmaceutical Co.,Ltd | 134.21B |
| AptaBio Therapeutics | 123.47B |
| Kyongbo Pharmaceutical | 123.12B |